{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:13:58Z","timestamp":1761513238841,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.3816\/cbc.2007.n.033","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T21:05:21Z","timestamp":1221080721000},"page":"716-718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Remission of Porphyria Cutanea Tarda After Anastrozole Treatment of Breast Cancer"],"prefix":"10.3816","volume":"7","author":[{"given":"Luigi F.","family":"Bertoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James C.","family":"Barton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CBC.2007.n.033_bib1","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1172\/JCI108560","article-title":"An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity","volume":"58","author":"Kushner","year":"1976","journal-title":"J Clin Invest"},{"key":"10.3816\/CBC.2007.n.033_bib2","first-page":"487","article-title":"The porphyrias","volume":"3","author":"Bonkovsky","year":"2000","journal-title":"Gastroenterol"},{"key":"10.3816\/CBC.2007.n.033_bib3","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1046\/j.1523-1747.2000.00148.x","article-title":"Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda","volume":"115","author":"Brady","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.3816\/CBC.2007.n.033_bib4","first-page":"845","article-title":"Precipitating\/aggravating factors of porphyria cutanea tarda in Spanish patients","volume":"48","author":"Cruz-Rojo","year":"2002","journal-title":"Cell Mol Biol"},{"key":"10.3816\/CBC.2007.n.033_bib5","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/hep.510270627","article-title":"Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America","volume":"27","author":"Bonkovsky","year":"1998","journal-title":"Hepatology"},{"key":"10.3816\/CBC.2007.n.033_bib6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000249898","article-title":"Porphyria cutanea tarda and pregnancy","volume":"166","author":"Goerz","year":"1983","journal-title":"Dermatologica"},{"key":"10.3816\/CBC.2007.n.033_bib7","first-page":"653","article-title":"Porphyria cutanea tarda: comparison of cases precipitated by alcohol and estrogens","volume":"113","author":"Haberman","year":"1975","journal-title":"Can Med Assoc J"},{"key":"10.3816\/CBC.2007.n.033_bib8","first-page":"755","article-title":"Porphyria cutanea tarda induced by natural estrogens. A case report","volume":"38","author":"Stein","year":"1971","journal-title":"Obstet Gynecol"},{"key":"10.3816\/CBC.2007.n.033_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1385\/MO:19:2:121","article-title":"Tamoxifen-related porphyria cutanea tarda","volume":"19","author":"Agarwal","year":"2002","journal-title":"Med Oncol"},{"key":"10.3816\/CBC.2007.n.033_bib10","first-page":"536","article-title":"Porphyria cutanea tarda after antineoplastic drugs [in Czech]","volume":"138","author":"Malina","year":"1999","journal-title":"Cas Lek Cesk"},{"key":"10.3816\/CBC.2007.n.033_bib11","first-page":"262","article-title":"Is tamoxifen porphyrinogenic? [in Czech]","volume":"144","author":"Malina","year":"2005","journal-title":"Cas Lek Cesk"},{"key":"10.3816\/CBC.2007.n.033_bib12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/bcmd.1997.0129","article-title":"Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis","volume":"23","author":"Barton","year":"1997","journal-title":"Blood Cells Mol Dis"},{"key":"10.3816\/CBC.2007.n.033_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004280100401","article-title":"C282Y and H63D mutation of the hemochromatosis gene in German porphyria cutanea tarda patients","volume":"439","author":"Tannapfel","year":"2001","journal-title":"Virchows Arch"},{"key":"10.3816\/CBC.2007.n.033_bib14","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0168-8278(98)80313-9","article-title":"The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients","volume":"28","author":"Stuart","year":"1998","journal-title":"J Hepatol"},{"key":"10.3816\/CBC.2007.n.033_bib15","first-page":"107","article-title":"Phlebotomy treatment of porphyria cutanea tarda","volume":"100","author":"Lundvall","year":"1982","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.3816\/CBC.2007.n.033_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1158\/1055-9965.EPI-03-0188","article-title":"Increased prevalence of the HFE C282Y hemochromatosis allele in women with breast cancer","volume":"13","author":"Kallianpur","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.3816\/CBC.2007.n.033_bib17","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/1055-9965.EPI-05-0013","article-title":"Investigation of genetic variants of genes of the hemochromatosis pathway and their role in breast cancer","volume":"14","author":"Abraham","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.3816\/CBC.2007.n.033_bib18","first-page":"815","article-title":"Geographic and racial\/ethnic differences in HFE mutation frequencies in the Hemochromatosis and Iron Overload Screening (HEIRS) Study","volume":"16","author":"Acton","year":"2006","journal-title":"Ethn Dis"},{"key":"10.3816\/CBC.2007.n.033_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2407-6-37","article-title":"HFE H63D mutation frequency shows an increase in Turkish women with breast cancer","volume":"6","author":"Gunel-Ozcan","year":"2006","journal-title":"BMC Cancer"},{"key":"10.3816\/CBC.2007.n.033_bib20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbadis.2005.09.003","article-title":"Frequency of hemochromatosis gene (HFE) mutations in Russian healthy women and patients with estrogen-dependent cancers","volume":"1762","author":"Kondrashova","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.3816\/CBC.2007.n.033_bib21","doi-asserted-by":"crossref","first-page":"932","DOI":"10.7326\/0003-4819-129-11_Part_2-199812011-00003","article-title":"Management of hemochromatosis. Hemochromatosis Management Working Group","volume":"129","author":"Barton","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.3816\/CBC.2007.n.033_bib22","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/0016-5085(88)90191-6","article-title":"Development of porphyria cutanea tarda after treatment with cyclophosphamide","volume":"95","author":"Manzione","year":"1988","journal-title":"Gastroenterol"},{"key":"10.3816\/CBC.2007.n.033_bib23","first-page":"95","article-title":"Appearance of an inherited porphyria cutanea tarda in a child after allogeneic bone marrow transplantation for chronic myelogenous leukaemia","volume":"1","author":"Dopfer","year":"1986","journal-title":"Bone Marrow Transpl"},{"key":"10.3816\/CBC.2007.n.033_bib24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1445-5994.1992.tb02154.x","article-title":"5-Fluorouracil-induced pseudoporphyria","volume":"22","author":"Laidman","year":"1992","journal-title":"Aust J Med"},{"key":"10.3816\/CBC.2007.n.033_bib25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mjd.2000.111338","article-title":"Pseudoporphyria","volume":"44","author":"Green","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CBC.2007.n.033_bib26","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1067\/mlc.2000.111024","article-title":"Transdermal estrogen replacement therapy in postmenopausal women previously treated for porphyria cutanea tarda","volume":"136","author":"Bulaj","year":"2000","journal-title":"J Lab Clin Med"},{"year":"2005","series-title":"Arimidex\u00ae anastrozole tablets [package insert]","key":"10.3816\/CBC.2007.n.033_bib27"},{"key":"10.3816\/CBC.2007.n.033_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","article-title":"Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer","volume":"365","author":"Howell","year":"2005","journal-title":"Lancet"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820911707686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820911707686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:10:46Z","timestamp":1761513046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820911707686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S1526820911707686"],"URL":"https:\/\/doi.org\/10.3816\/cbc.2007.n.033","relation":{},"ISSN":["1526-8209"],"issn-type":[{"type":"print","value":"1526-8209"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Remission of Porphyria Cutanea Tarda After Anastrozole Treatment of Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CBC.2007.n.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}